Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) EBT Margin (2020 - 2022)

Immuneering has reported EBT Margin over the past 3 years, most recently at 2960184.4% for Q4 2022.

  • Quarterly results put EBT Margin at 2960184.4% for Q4 2022, down 295439674.0% from a year ago — trailing twelve months through Sep 2023 was 11588326.59% (down 1157879575.0% YoY), and the annual figure for FY2022 was 15937.29%, down 1431018.0%.
  • EBT Margin for Q4 2022 was 2960184.4% at Immuneering, down from 33781.04% in the prior quarter.
  • Over the last five years, EBT Margin for IMRX hit a ceiling of 644.49% in Q3 2020 and a floor of 2960184.4% in Q4 2022.
  • Median EBT Margin over the past 3 years was 1768.4% (2021), compared with a mean of 274998.48%.
  • Biggest five-year swings in EBT Margin: plummeted -46062bps in 2021 and later plummeted -295439674bps in 2022.
  • Immuneering's EBT Margin stood at 877.48% in 2020, then plummeted by -560bps to 5787.65% in 2021, then crashed by -51047bps to 2960184.4% in 2022.
  • The last three reported values for EBT Margin were 2960184.4% (Q4 2022), 33781.04% (Q3 2022), and 12183.19% (Q2 2022) per Business Quant data.